Head-to-head · WeighScore
Alan Meds vs LifeMD
By GLP-1 ScorecardUpdated
Score comparison
Alan Meds has the higher recorded score — 65.7/100 to 57.8/100.
Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alan Health, also known as Alan Meds, advertises compounded injection and sublingual options alongside branded prescription options.
Before you choose
Before comparing the headline prices, the Alan Meds review and the LifeMD review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, Alan Meds vs No BS RX and CoreAge Rx vs LifeMD compare each of them with another graded program, and the list of alternatives to Alan Meds ranks the programs closest to Alan Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the SkinnyRx review covers one graded close to these two, at 60.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Alan Meds | LifeMD |
|---|---|---|
| WeighScore | 65.7/100 | 57.8/100 |
| Grade | C | C |
| Site position | #231 | #423 |
| Semaglutide | $158/mo equivalent (2-month upfront promotion, compounded) | Brand Wegovy from $199 (pen) or $149 (pill); plus a program fee of $39 the first month, then $149/mo (the page also cites $75/mo) |
| Tirzepatide | $325/mo equivalent (6-month upfront plan, compounded) | Brand Zepbound vial from $299; plus a program fee of $39 the first month, then $149/mo |
| Coverage | Eligibility depends on state, prescription and pharmacy | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #231 · C
FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.
Strengths
- Advertised compounded injection pricing stays the same across doses
- Online care with a choice of injection and sublingual preparations
- Outside-pharmacy choice described; separate charges may apply
- Public catalog lists branded Wegovy and Zepbound options
What to consider
- Lowest compounded price labels require upfront multi-month payment
- First renewal may process early; cancel before the actual processing deadline
- Unused subscription periods are not refundable under the ordinary terms
- Rejection-refund promise differs from broader medical-consent wording
Strengths
- Telehealth convenience
- Physician-supervised program
What to consider
- Brand-name GLP-1 only — no lower-cost compounded option
- Monthly program & provider fee ($149/mo, $75 first month) is separate from medication cost
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.